CAMP Q4 2018 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$88M-5.5% YoY

Gross Profit

$36M41.1% margin

Operating Income

$599,0000.7% margin

Net Income

-$522,000-0.6% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

-7.9%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$608M

Total Liabilities

$406M

Stockholders' Equity

$202M

Cash & Equivalents

$272M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$94M	-5.5%
Gross Profit	$36M	$38M	-4.7%
Operating Income	$599,000	$4M	-85.8%
Net Income	-$522,000	$12M	-104.4%

Revenue Segments

Product

$68M76%

Application Subscriptions And Related Products And Other Services

$21M24%

Geographic Segments

UNITED STATES

$67M76%

E M E A

$10M12%

All Other

$4M4%

Asia Pacific

$3M4%

CANADA

$3M4%

South America

$832,0001%